Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Grifols SA

GIFLF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001438569

No open-market purchases or sales by Grifols SA insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesGRFSGIFOFGIKLY

Key figures

Market capNo recent share count in SEC filings
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Financials

See financial statements

From SEC filings, in EUR.

Revenue, FY2024
EUR 7.21B
+9.4% year over year
Net income, FY2024
EUR 212.8M
+17.8% year over year
Free cash flow, FY2024
EUR 669.6M
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
3.08M
Shares sold short
Change
−288.5K
−8.6% vs. previous
Days to cover
> 999
Above FINRA's cap of 999.99 days

Superinvestors holding GIFLF, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding GIFLF at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Grifols SA insiders from Form 4, newest first.

No open-market purchases or sales by Grifols SA insiders are on file.

Top 10 13F holders, Q2 2026

View all: Top 10 13F holders, Q2 2026

The largest institutional positions in Grifols SA at the end of Q2 2026; share changes are against Q1 2026.

No institution reported holding GIFLF in 13F filings for Q2 2026.

Politician trades

All politician trades in GIFLF

2 members of Congress reported 3 trades in Grifols SA since 2020. Newest filings:

  1. Daniel S. Goldman

    House · NY · Apr 17, 2023

    Sell$1K-$15K

  2. Daniel S. Goldman

    House · NY · Mar 20, 2023

    Buy$1K-$15K

  3. Donna E. Shalala

    House · FL · Apr 27, 2020

    Sell$1K-$15K